Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
02/09/2011 | EP1280898B1 Modified es cells and es cell-specific gene |
02/09/2011 | EP0848755B2 Vegf-related protein |
02/09/2011 | EP0668777B2 Prostate-specific membrane antigen |
02/09/2011 | CN1859926B Polymer encapsulation of adenoviruses |
02/09/2011 | CN101970645A Method for producing vaccinal viral strain of a virus of the reoviridae family |
02/09/2011 | CN101970013A Novel therapeutical tools and methods for treating blindness |
02/09/2011 | CN101967495A Construction of C35 gene siRNA expression vector of breast cancer cell and antineoplastic therapy application |
02/09/2011 | CN101967187A Protein related to cell stress, and coding gene and application thereof |
02/09/2011 | CN101967186A Encephalitis virus protein and code gene and application thereof |
02/09/2011 | CN101967185A Encephalitis virus protein as well as coding gene and application thereof |
02/09/2011 | CN101966341A Adenovirus/viruses A replicon chimeric vector hogcholeravaccine and application thereof |
02/09/2011 | CN101966337A Genetic products differentially expressed in tumors and the use thereof |
02/09/2011 | CN101966336A Recombinant attenuated salmonella typhimurium vector vaccine for expressing CSFV (Classical Swine Fever Virus) immunogenic gene and preparation method thereof |
02/09/2011 | CN101966332A Application of gap junction protein and coding gene thereof in preparing medicament for reversing malignant phenotype of cancer stem cell |
02/09/2011 | CN101020044B Regulating and controlling effect of thymine DNA glycosylase on signal transducing path |
02/08/2011 | US7884179 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
02/08/2011 | US7884084 Oligonucleotide seqences for controlling expression of leptin receptor gene associated protein (OB-RGRP); for treatment and prevention of bone, thrombic, sexual, blood, immunological, inflammatory and cancer disorders |
02/08/2011 | US7884082 Combined therapeutical treatment of hyperproliferative diseases |
02/08/2011 | US7883896 for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as lung adenocarcinoma, lung carcinoma |
02/08/2011 | US7883889 Using 5-aza-cytidine or 5-aza-2'-deoxycytidine to hypomethylate cells expressing tumor associated antigens; immunotherapy; genetic vaccines and the diagnosis, prevention and treatment of cancer |
02/08/2011 | US7883880 DNA polymerase lambda and uses thereof |
02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
02/08/2011 | US7883720 Charge-dynamic polymers and delivery of anionic compounds |
02/08/2011 | US7883696 deliver transgenes of interest and suppressors of the eukaryotic Type I interferon response to eukaryotic cells; Suppression of the eukaryotic Type I interferon response allows improved expression of the encoded transgene |
02/08/2011 | US7883688 Polycationic polyrotaxanes capable of forming complexes with nucleic acids |
02/08/2011 | CA2320419C Compositions comprising viruses and methods for concentrating virus preparations |
02/08/2011 | CA2295971C Pseudomonas exotoxin a-like chimeric immunogens |
02/08/2011 | CA2273825C Cytopathic viruses for therapy and prophylaxis of neoplasia |
02/08/2011 | CA2217967C Augmentation in serca2 mediated calcium ion transport for regulation of cardiac muscle contractility |
02/08/2011 | CA2210467C Osteoprotegerin |
02/08/2011 | CA2164226C Methods for selectively stimulating proliferation of t cells |
02/03/2011 | WO2011014388A1 Adipose-derived stromal cells (asc) as delivery tool for treatment of cancer |
02/03/2011 | WO2011013700A1 Carrier peptide fragment and use thereof |
02/03/2011 | WO2011013699A1 Carrier peptide fragment and use thereof |
02/03/2011 | WO2011013698A1 Carrier peptide fragment and use thereof |
02/03/2011 | WO2011012724A1 Widespread gene delivery to the retina using systemic administration of aav vectors |
02/03/2011 | WO2011012716A1 Oligonucleotides inhibiting cellular migration |
02/03/2011 | WO2011012707A1 PRODUCTION OF β-CELLS |
02/03/2011 | WO2011011927A1 Use of rnf13 protein and encoding gene thereof in the preparation of medicaments for preventing and/or treating mental cognitive disorders |
02/03/2011 | WO2010053597A3 Micelles of hydrophilically shielded membrane-destabilizing copolymers |
02/03/2011 | WO2007035872A3 Tdf-related compounds and analogs thereof |
02/03/2011 | US20110028691 Recombinant toxin fragments |
02/03/2011 | US20110028690 Novel bag proteins and nucleic acid molecules encoding them |
02/03/2011 | US20110028537 Somatic cell reprogramming |
02/03/2011 | US20110028535 Oligonucleotides-transferring preparations |
02/03/2011 | US20110027883 Rna interference mediating small rna molecules |
02/03/2011 | US20110027879 Adipose-derived stem cells and lattices |
02/03/2011 | US20110027319 Methods of eliciting or boosting a cellular immune response |
02/03/2011 | US20110027318 Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis |
02/03/2011 | US20110027306 TC-83-Derived Alphavirus Vectors, Particles and Methods |
02/03/2011 | US20110027279 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
02/03/2011 | US20110027241 Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells |
02/03/2011 | US20110027240 Secretable hiv entry inhibitory peptides for therapy of hiv infection |
02/03/2011 | US20110027237 Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells |
02/03/2011 | US20110027231 Method for the random diversification of a genetic sequence while preserving the identity of some inner segments of said genetic sequence |
02/03/2011 | CA2769745A1 Widespread gene delivery to the retina using systemic administration of aav vectors |
02/03/2011 | CA2769538A1 Oligonucleotides inhibiting cellular migration |
02/02/2011 | EP2280082A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours |
02/02/2011 | EP2280074A2 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof |
02/02/2011 | EP2280070A1 Methods and compositions for RNAi mediated inhibition of gene expression in mammals |
02/02/2011 | EP2280066A2 Recombinant Clostridium neurotoxin fragments |
02/02/2011 | EP2280030A2 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
02/02/2011 | EP2280019A1 Antisense modulation of C-reactive protein expression |
02/02/2011 | EP2279253A2 Engineering and delivery of therapeutic compositions of freshly isolated cells |
02/02/2011 | EP1875247B1 Selective modulation of tumour necrosis factor receptors in therapy |
02/02/2011 | CN1844387B Antisense oligonucleotide structure inhibiting Sirt1 gene expression and use thereof |
02/02/2011 | CN101965196A Sugar chain-related gene and use thereof |
02/02/2011 | CN101962648A Duck source coronavirus ORF1a protein gene and cloning method and application thereof |
02/02/2011 | CN101962642A Interference RNA for targeting CCP22 gene, medicament composition containing interference RNA and application thereof |
02/02/2011 | CN101962413A Fusion protein with transdermal capability and interleukin-10 activity as well as coding gene and application thereof |
02/02/2011 | CN101961497A Inhibition of Syk kinase expression |
02/02/2011 | CN101961493A Ace2 activation for treatment of heart, lung and kidney disease and hypertension |
02/02/2011 | CN101575604B Slow virus vector, preparation thereof and application thereof |
02/01/2011 | US7879993 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
02/01/2011 | US7879989 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cell proliferative disorders |
02/01/2011 | US7879966 pH-sensitive polymer |
02/01/2011 | US7879811 Formulations comprising antisense nucleotides to connexins |
02/01/2011 | US7879810 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines |
02/01/2011 | US7879791 Regulation of T cell-mediated immunity by tryptophan |
02/01/2011 | US7879609 Regulatory segments of the human gene for telomerase reverse transcriptase |
02/01/2011 | US7879605 Methods and compositions for tissue regeneration |
02/01/2011 | US7879602 Plasmid comprising toll-like receptor-3 (TLR-3) agonist promoter and influenza virus HA, influenza virus Ml, influenza virus NP and/or human immunodeficiency viral proteins; for use in eliciting antigen response in mammals |
02/01/2011 | US7879588 Protein-proteophore complexes |
02/01/2011 | US7879577 Modified polypeptides stabilized in a desired conformation and methods for producing same |
02/01/2011 | US7879570 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
02/01/2011 | US7879340 blocking, reducing allergic rhinitis via antibodies contacting antigen, by administration of neurotoxin derived from Clostridium; absorbent pledgets, biodegradable carriers; lyophilization; liposomes |
02/01/2011 | US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders |
02/01/2011 | US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction |
02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
02/01/2011 | CA2547256C Adenovirus-transfected primary cells and methods of pathway mapping |
02/01/2011 | CA2445260C Buffer solution for electroporation and a method comprising the use of the same |
02/01/2011 | CA2380550C C type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
02/01/2011 | CA2359013C Compositions and methods for packaging of alphavirus vectors |
02/01/2011 | CA2354508C Streptococcal c5a peptidase vaccine |
02/01/2011 | CA2288943C Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
02/01/2011 | CA2282779C Formulation comprising an antigen, an adjuvant and an amino acid for use in immunization. |
02/01/2011 | CA2222279C Hypoxia inducible factor-1 and method of use |
01/27/2011 | WO2011011700A2 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
01/27/2011 | WO2011011631A2 Nucleic acid delivery vehicles |
01/27/2011 | WO2011011061A2 Method of regulating angiogenesis and lymphangiogenesis, and a pharmaceutical composition for effecting anti-angiogenic and anti-lymphangiogenic cancer therapy |